Prospective and Non-randomized Registry of CardioCel 3D
Post-Market Registry in Europe for the Use of CardioCel®, CardioCel® Neo and CardioCel® 3D
Sponsor: Factory CRO for Medical Devices B.V.
Listed as NCT04175327, this observational or N/A phase trial focuses on Great Vessel Reconstruction and Intracardiac and Septal Defects and remains ongoing. Sponsored by Factory CRO for Medical Devices B.V., it has been updated 11 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Apr 2025 — Present [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — Mar 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jun 2022 — Apr 2023 [monthly]
Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Recruiting
-
Feb 2021 — Jun 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
-
May 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Dec 2019 — May 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Factory CRO for Medical Devices B.V.
- LeMaitre Vascular
For direct contact, visit the study record on ClinicalTrials.gov .